79 related articles for article (PubMed ID: 23318052)
1. Expression of disintegrin and metalloproteinase family proteins 10, 12 and 17 in cholesteatoma.
Erbek S; Erinanc H; Hizal E; Ozluoglu LN
J Laryngol Otol; 2013 Feb; 127(2):153-8. PubMed ID: 23318052
[TBL] [Abstract][Full Text] [Related]
2. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
3. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Li Y; Xu Z; Zhang L; Quan C; Lin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
[TBL] [Abstract][Full Text] [Related]
4. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
5. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
[TBL] [Abstract][Full Text] [Related]
6. The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis.
Mehta D; Daudia A; Birchall JP; Banerjee AR
Acta Otolaryngol; 2007 Feb; 127(2):138-42. PubMed ID: 17364344
[TBL] [Abstract][Full Text] [Related]
7. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
[TBL] [Abstract][Full Text] [Related]
8. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
[TBL] [Abstract][Full Text] [Related]
9. [The expression and significance of DDR2 and MMP-13in human middle ear cholesteatoma].
Xu LF; Sun WZ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):938-941. PubMed ID: 29771058
[No Abstract] [Full Text] [Related]
10. [The expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in cholesteatoma].
Li N; Qin Z; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):424-6. PubMed ID: 15499988
[TBL] [Abstract][Full Text] [Related]
11. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study.
Lei Y; An J; Ren Q; Wang M; Gao M
Medicine (Baltimore); 2023 Oct; 102(43):e35538. PubMed ID: 37904429
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
Zhang E; Gong S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
14. Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.
Miyazaki H; Kojima H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Laryngoscope; 1999 Nov; 109(11):1785-92. PubMed ID: 10569408
[TBL] [Abstract][Full Text] [Related]
15. [Expression of matrix metalloproteinase-2,9 in cholesteatoma from different positions].
Wang J; Yu LS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):44-8. PubMed ID: 19484988
[TBL] [Abstract][Full Text] [Related]
16. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
17. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
18. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
19. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
Xu Y; Wu Z; Tao Z; Hua Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
[TBL] [Abstract][Full Text] [Related]
20. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
Shibosawa E; Tsutsumi K; Takakuwa T; Takahashi S
Am J Otol; 2000 Sep; 21(5):621-4. PubMed ID: 10993447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
